MPM ASSET MANAGEMENT LLC - SYNDAX PHARMACEUTICALS INC ownership

SYNDAX PHARMACEUTICALS INC's ticker is SNDX and the CUSIP is 87164F105. A total of 72 filers reported holding SYNDAX PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
MPM ASSET MANAGEMENT LLC ownership history of SYNDAX PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2020$27,208,000
-15.3%
1,843,388
-15.0%
5.07%
-46.9%
Q2 2020$32,140,000
+35.1%
2,168,6910.0%9.56%
-33.9%
Q1 2020$23,791,000
+24.9%
2,168,6910.0%14.47%
+72.7%
Q4 2019$19,041,000
+17.5%
2,168,6910.0%8.38%
+20.9%
Q3 2019$16,200,000
-19.8%
2,168,6910.0%6.93%
-15.0%
Q2 2019$20,191,000
+77.3%
2,168,6910.0%8.16%
+73.8%
Q1 2019$11,386,000
+18.0%
2,168,6910.0%4.70%
-42.5%
Q4 2018$9,651,000
-44.9%
2,168,6910.0%8.17%
-31.2%
Q3 2018$17,523,000
+15.1%
2,168,6910.0%11.86%
+101.2%
Q2 2018$15,224,000
-50.7%
2,168,6910.0%5.90%
-50.4%
Q1 2018$30,860,000
+62.4%
2,168,6910.0%11.89%
+56.1%
Q4 2017$18,998,000
-25.1%
2,168,6910.0%7.61%
-38.5%
Q3 2017$25,374,000
-16.2%
2,168,6910.0%12.38%
-5.9%
Q2 2017$30,297,000
+1.8%
2,168,6910.0%13.16%
-8.0%
Q1 2017$29,754,000
+91.3%
2,168,6910.0%14.31%
+95.0%
Q4 2016$15,550,000
-52.7%
2,168,6910.0%7.34%
-31.8%
Q3 2016$32,877,000
+53.9%
2,168,6910.0%10.77%
+55.4%
Q2 2016$21,362,000
-26.0%
2,168,6910.0%6.93%
-22.6%
Q1 2016$28,887,0002,168,6918.95%
Other shareholders
SYNDAX PHARMACEUTICALS INC shareholders Q1 2019
NameSharesValueWeighting ↓
Aisling Capital Management LP 1,025,000$19,588,0003.91%
Ghost Tree Capital, LLC 575,000$10,988,0003.21%
Avidity Partners Management LP 4,823,400$92,175,0002.04%
BVF INC/IL 2,486,429$47,516,0001.85%
FRAZIER MANAGEMENT LLC 1,188,135$22,705,0001.82%
Nantahala Capital Management 2,657,159$50,778,0001.60%
Boxer Capital, LLC 2,287,782$43,720,0001.53%
ACUTA CAPITAL PARTNERS, LLC 206,126$3,939,0001.39%
SPHERA FUNDS MANAGEMENT LTD. 750,603$14,344,0001.20%
PFM Health Sciences, LP 1,856,738$35,482,0001.04%
View complete list of SYNDAX PHARMACEUTICALS INC shareholders